These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 23955316

  • 1. Effect of lipophilicity on microneedle-mediated iontophoretic transdermal delivery across human skin in vitro.
    Pawar KR, Smith F, Kolli CS, Babu RJ.
    J Pharm Sci; 2013 Oct; 102(10):3784-91. PubMed ID: 23955316
    [Abstract] [Full Text] [Related]

  • 2. Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin.
    Pawar K, Kolli CS, Rangari VK, Babu RJ.
    J Pharm Sci; 2017 Jul; 106(7):1814-1820. PubMed ID: 28343991
    [Abstract] [Full Text] [Related]

  • 3. Dissolving polymeric microneedle arrays for electrically assisted transdermal drug delivery.
    Garland MJ, Caffarel-Salvador E, Migalska K, Woolfson AD, Donnelly RF.
    J Control Release; 2012 Apr 10; 159(1):52-9. PubMed ID: 22265694
    [Abstract] [Full Text] [Related]

  • 4. Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate.
    Kolli CS, Xiao J, Parsons DL, Babu RJ.
    Drug Dev Ind Pharm; 2012 May 10; 38(5):571-6. PubMed ID: 21980925
    [Abstract] [Full Text] [Related]

  • 5. Microneedle-iontophoresis combinations for enhanced transdermal drug delivery.
    Donnelly RF, Garland MJ, Alkilani AZ.
    Methods Mol Biol; 2014 May 10; 1141():121-32. PubMed ID: 24567135
    [Abstract] [Full Text] [Related]

  • 6. Increased microneedle-mediated transdermal delivery of tetramethylpyrazine to the brain, combined with borneol and iontophoresis, for MCAO prevention.
    Xiao S, Yan Y, Zhao J, Zhang Y, Feng N.
    Int J Pharm; 2020 Feb 15; 575():118962. PubMed ID: 31857187
    [Abstract] [Full Text] [Related]

  • 7. In vivo iontophoretic delivery of salmon calcitonin across microporated skin.
    Vemulapalli V, Bai Y, Kalluri H, Herwadkar A, Kim H, Davis SP, Friden PM, Banga AK.
    J Pharm Sci; 2012 Aug 15; 101(8):2861-9. PubMed ID: 22644951
    [Abstract] [Full Text] [Related]

  • 8. Iontophoretic delivery of lipophilic and hydrophilic drugs from lipid nanoparticles across human skin.
    Charoenputtakun P, Li SK, Ngawhirunpat T.
    Int J Pharm; 2015 Nov 10; 495(1):318-328. PubMed ID: 26325320
    [Abstract] [Full Text] [Related]

  • 9. Controlled delivery of ropinirole hydrochloride through skin using modulated iontophoresis and microneedles.
    Singh ND, Banga AK.
    J Drug Target; 2013 May 10; 21(4):354-66. PubMed ID: 23311703
    [Abstract] [Full Text] [Related]

  • 10. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
    Gratieri T, Pujol-Bello E, Gelfuso GM, de Souza JG, Lopez RF, Kalia YN.
    Eur J Pharm Biopharm; 2014 Feb 10; 86(2):219-26. PubMed ID: 23791718
    [Abstract] [Full Text] [Related]

  • 11. Transdermal delivery of atenolol: effect of prodrugs and iontophoresis.
    Anroop B, Ghosh B, Parcha V, Khanam J.
    Curr Drug Deliv; 2009 Jul 10; 6(3):280-90. PubMed ID: 19604142
    [Abstract] [Full Text] [Related]

  • 12. Iontophoretic in vivo transdermal delivery of beta-blockers in hairless rats and reduced skin irritation by liposomal formulation.
    Conjeevaram R, Chaturvedula A, Betageri GV, Sunkara G, Banga AK.
    Pharm Res; 2003 Sep 10; 20(9):1496-501. PubMed ID: 14567646
    [Abstract] [Full Text] [Related]

  • 13. A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl.
    Silva SM, Hu L, Sousa JJ, Pais AA, Michniak-Kohn BB.
    Eur J Pharm Biopharm; 2012 Apr 10; 80(3):663-73. PubMed ID: 22137964
    [Abstract] [Full Text] [Related]

  • 14. In vitro transdermal iontophoretic delivery of penbutolol sulfate.
    Ita KB, Banga AK.
    Drug Deliv; 2009 Jan 10; 16(1):11-4. PubMed ID: 19555303
    [Abstract] [Full Text] [Related]

  • 15. Effect of lipophilicity on in vivo iontophoretic delivery. II. Beta-blockers.
    Tashiro Y, Sami M, Shichibe S, Kato Y, Hayakawa E, Itoh K.
    Biol Pharm Bull; 2001 Jun 10; 24(6):671-7. PubMed ID: 11411557
    [Abstract] [Full Text] [Related]

  • 16. Transdermal absorption of memantin--effect of chemical enhancers, iontophoresis, and role of enhancer lipophilicity.
    del Rio-Sancho S, Serna-Jiménez CE, Calatayud-Pascual MA, Balaguer-Fernández C, Femenía-Font A, Merino V, López-Castellano A.
    Eur J Pharm Biopharm; 2012 Sep 10; 82(1):164-70. PubMed ID: 22732268
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin.
    Nair A, Vyas H, Shah J, Kumar A.
    Drug Deliv; 2011 Jan 10; 18(1):19-25. PubMed ID: 20726811
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.